Cystic Fibrosis Clinical Trial
Official title:
Effects of an Individualized and Partially Supervised Exercise Program on Parameters of Physical Fitness, Lung Function, Habitual Physical Activity in Daily Life and Quality of Life in Children, Adolescents and Adults With Cystic Fibrosis.
Verified date | January 2019 |
Source | University Hospital, Essen |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to evaluate the effects of a partially supervised exercise program on different aspects of physical fitness, despite VO2peak, lung function, quality of life and sleep quality in children, adolescents and adults with Cystic Fibrosis.
Status | Completed |
Enrollment | 100 |
Est. completion date | August 10, 2018 |
Est. primary completion date | August 10, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 6 Years and older |
Eligibility |
Inclusion Criteria: - Confirmed diagnosis of CF - Informed consent Exclusion Criteria: - Cardiac arrhythmias with exercise - Patients with cor pulmonale - Colonization with Burkholderia cenocepacia, Methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant Gram-negative (MRGN) pathogens (3 and 4 MRGN) - Patients with untreated diabetes |
Country | Name | City | State |
---|---|---|---|
Germany | St. Josef-Hospital im Katholischen Klinikum Bochum, Klinik für Kinder und Jugendmedizin, Alexandrinenstrasse 5 | Bochum | |
Germany | Ruhrlandklinik Essen, Westdeutsches Lungenzentrum am Universitätsklinikum Essen, Tuschener Weg 40 | Essen | |
Germany | Universitätsklinikum Essen, Klinik für Kinderheilkunde III, Pädiatrische Pneumologie und Schlafmedizin, Hufelandstr. 55 | Essen |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Essen |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change of habitual physical activity in hours/day | Measurement of the time of physical activity in hours/day by accelerometry (ActiGraph GT3X, Penascola, USA) | at baseline, after 6 and 12 month | |
Secondary | Change of the quality of life in Cystic Fibrosis | Measurement of the quality of life by the Cystic Fibrosis Questionnaire Revised (CFQ-R, Quality of life domains: Physical, role/school, vitality, emotion, social, body image, eating, treatment burden, health perceptions. Symptom scales: Weight, respiratory, and digestion) | at baseline, after 6 and 12 month | |
Secondary | Change of the duration of sleep in hours | Measurement of the duration of sleep in hours by accelerometry (ActiGraph GT3X, Penascola, USA) | at baseline, after 6 and 12 month | |
Secondary | Change of the quality of sleep in percent | Measurement of the quality of sleep in percent by accelerometry (ActiGraph GT3X, Penascola, USA) | at baseline, after 6 and 12 month | |
Secondary | Determination of the exercise related barriers and barrier management in physical exercise | specific questionnaire (Barrieren und Barrierenmanagementim Prozess der Sportteilnahme, Krämer and Fuchs, Zeitschrift für Gesundheitspsychologie, 18(4), 170-182, 2010) | at baseline | |
Secondary | Change of habitual physical activity in steps/day | Measurement of the number of steps/day by accelerometry (ActiGraph GT3X, Penascola, USA) | at baseline, after 6 and 12 month | |
Secondary | Change of habitual physical activity spend in light intensity (= 3METS) in minutes | Measurement of the time of habitual physical activity spend in light intensity (= 3METS) in minutes by accelerometry (ActiGraph GT3X, Penascola, USA) | at baseline, after 6 and 12 month | |
Secondary | Change of habitual physical activity spend in moderate to vigorous intensity (3 to 5.9 METS) in minutes by accelerometry (ActiGraph GT3X, Penascola, USA) | Measurement of the time of habitual physical activity spend in moderate to vigorous intensity (3 to 5.9 METS) in minutes by accelerometry (ActiGraph GT3X, Penascola, USA) | at baseline, after 6 and 12 month | |
Secondary | Change of habitual physical activity spend in vigorous intensity (6 to 8.99 METS) in minutes by accelerometry (ActiGraph GT3X, Penascola, USA) | Measurement of the time of habitual physical activity spend in vigorous intensity (6 to 8.99 METS) in minutes by accelerometry (ActiGraph GT3X, Penascola, USA) | at baseline, after 6 and 12 month | |
Secondary | Change of habitual physical activity spend in hard intensity (= 9 METS) in minutes by accelerometry (ActiGraph GT3X, Penascola, USA) | Measurement of the time of habitual physical activity spend in hard intensity (= 9 METS) in minutes by accelerometry (ActiGraph GT3X, Penascola, USA) | at baseline, after 6 and 12 month | |
Secondary | Change of maximal exercise capacity expressed as heart rate | Measurement of heart rate in b/min by cycle ergometry (Ergoselect 100p, Ergoline, Bitz, Germany) | at baseline, after 6 and 12 month | |
Secondary | Change of maximal exercise capacity expressed as heart rate reserve in percent | Measurement of heart rate reserve in percent by cycle ergometry (Ergoselect 100p, Ergoline, Bitz, Germany) | at baseline, after 6 and 12 month | |
Secondary | Change of maximal exercise capacity expressed as workload in Watt | Measurement of workload in Watt by cycle ergometry (Ergoselect 100p, Ergoline, Bitz, Germany) | at baseline, after 6 and 12 month | |
Secondary | Change of maximal exercise capacity expressed as workload in Watt / kg bodyweight | Measurement of workload in Watt / kg bodyweight by cycle ergometry (Ergoselect 100p, Ergoline, Bitz, Germany) | at baseline, after 6 and 12 month | |
Secondary | Change of maximal exercise capacity expressed as perceived exertion (Borg CR10 Scale) in number of level of exertion | Measurement of the Borg questionnaire (Borg CR10 Scale) | at baseline, after 6 and 12 month | |
Secondary | Change of skill / performance related fitness expressed as push-ups in number of repetition in 40 sec. | Measurement of push-ups in number of repetition in 40 sec. with the German motor test (Deutscher Motorik Test, Forschungszentrum für den Schulsport und den Sport von Kindern und Jugendlichen, Karlsruhe, Germany) in children and adolescents aged 6-18 years | at baseline, after 6 and 12 month | |
Secondary | Change of skill / performance related fitness expressed as standing broad jump in cm in children and adolescents | Measurement of standing broad jump in cm with the German motor test (Deutscher Motorik Test, Forschungszentrum für den Schulsport und den Sport von Kindern und Jugendlichen, Karlsruhe, Germany) aged 6-18 years | at baseline, after 6 and 12 month | |
Secondary | Change of skill / performance related fitness expressed as sit-up in number of repetition in 40 sec. | Measurement of sit-ups in number of repetition in 40 sec. with the German motor test (Deutscher Motorik Test, Forschungszentrum für den Schulsport und den Sport von Kindern und Jugendlichen, Karlsruhe, Germany) aged 6-18 years | at baseline, after 6 and 12 month | |
Secondary | Change of skill / performance related fitness expressed as balancing backwards number in steps on a wooden beam 6 cm wide and 3 meters long | Measurement of balancing backwards number in steps on a wooden beam 6 cm wide and 3 meters long with the German motor test (Deutscher Motorik Test, Forschungszentrum für den Schulsport und den Sport von Kindern und Jugendlichen, Karlsruhe, Germany) aged 6-18 years | at baseline, after 6 and 12 month | |
Secondary | Change of skill / performance related fitness expressed as jump sideways in number of repetition in 15 sec. | Measurement of balancing backwards number in jump sideways in number of repetition in 15 sec. with the German motor test (Deutscher Motorik Test, Forschungszentrum für den Schulsport und den Sport von Kindern und Jugendlichen, Karlsruhe, Germany) aged 6-18 years | at baseline, after 6 and 12 month | |
Secondary | Change of skill / performance related fitness expressed as flexibility in cm in children and adolescents | Measurement of flexibility in cm with the German motor test (Deutscher Motorik Test, Forschungszentrum für den Schulsport und den Sport von Kindern und Jugendlichen, Karlsruhe, Germany) aged 6-18 years | at baseline, after 6 and 12 month | |
Secondary | Change of skill / performance related fitness expressed as one leg stand in sec. | Measurement of one leg stand in sec. as included in the TFR (Test Fitness Rekrutierung, Bundesamt für Sport BASPO, Magglingen, Schweiz) in adults | at baseline, after 6 and 12 month | |
Secondary | Change of skill / performance related fitness expressed as standing broad jump in cm in adults | Measurement of standing broad jump in cm as included in the TFR (Test Fitness Rekrutierung, Bundesamt für Sport BASPO, Magglingen, Schweiz) in adults | at baseline, after 6 and 12 month | |
Secondary | Change of skill / performance related fitness expressed as trunk power in sec. | Measurement of trunk power in sec. as included in the TFR (Test Fitness Rekrutierung, Bundesamt für Sport BASPO, Magglingen, Schweiz) in adults | at baseline, after 6 and 12 month | |
Secondary | Change of skill / performance related fitness expressed as flexibility in cm in adults | Measurement of flexibility in cm as included in the basic motor diagnostics (Motorische Basisdiagnostik, Hrsg. Bös/Wydra/Karisch, 1992) in adults | at baseline, after 6 and 12 month | |
Secondary | Change of skill / performance related fitness expressed as circling motion in number of complete performed circles | Measurement of circling motion in number of complete performed circles as included in the basic motor diagnostics (Motorische Basisdiagnostik, Hrsg. Bös/Wydra/Karisch, 1992) in adults | at baseline, after 6 and 12 month | |
Secondary | Change of skill / performance related fitness expressed as the time of hip extension in sec. | Measurement of the time of hip extension in sec. as included in the basic motor diagnostics (Motorische Basisdiagnostik, Hrsg. Bös/Wydra/Karisch, 1992) in adults | at baseline, after 6 and 12 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04696198 -
Thoracic Mobility in Cystic Fibrosis Care
|
N/A | |
Completed |
NCT00803205 -
Study of Ataluren (PTC124™) in Cystic Fibrosis
|
Phase 3 | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03601637 -
Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Participants 1 to Less Than 2 Years of Age With Cystic Fibrosis, Homozygous for F508del
|
Phase 3 | |
Terminated |
NCT02769637 -
Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
|
||
Recruiting |
NCT06030206 -
Lung Transplant READY CF 2: A Multi-site RCT
|
N/A | |
Recruiting |
NCT06012084 -
The Development and Evaluation of iCF-PWR for Healthy Siblings of Individuals With Cystic Fibrosis
|
N/A | |
Recruiting |
NCT06032273 -
Lung Transplant READY CF 2: CARING CF Ancillary RCT
|
N/A | |
Recruiting |
NCT06088485 -
The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis
|
||
Recruiting |
NCT05392855 -
Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF)
|
N/A | |
Recruiting |
NCT04039087 -
Sildenafil Exercise: Role of PDE5 Inhibition
|
Phase 2/Phase 3 | |
Recruiting |
NCT04056702 -
Impact of Triple Combination CFTR Therapy on Sinus Disease.
|
||
Completed |
NCT04058548 -
Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary Exacerbation
|
N/A | |
Completed |
NCT04038710 -
Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.
|
||
Completed |
NCT03637504 -
Feasibility of a Mobile Medication Plan Application in CF Patient Care
|
N/A | |
Recruiting |
NCT03506061 -
Trikafta in Cystic Fibrosis Patients
|
Phase 2 | |
Completed |
NCT03566550 -
Gut Imaging for Function & Transit in Cystic Fibrosis Study 1
|
||
Recruiting |
NCT04828382 -
Prospective Study of Pregnancy in Women With Cystic Fibrosis
|
||
Completed |
NCT04568980 -
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
|
||
Recruiting |
NCT04010253 -
Impact of Bronchial Drainage Technique by the Medical Device Simeox® on Respiratory Function and Symptoms in Adult Patients With Cystic Fibrosis
|
N/A |